Literature DB >> 8634294

Ligand recognition by anti-DNA autoantibodies. Affinity, specificity, and mode of binding.

P C Swanson1, C Ackroyd, G D Glick.   

Abstract

Understanding the molecular basis of DNA recognition by anti-DNA autoantibodies is a key element in defining the role of antibody.DNA complexes in the pathogenesis of the autoimmune disorder systemic lupus erythematosus. As part of our efforts to relate anti-DNA affinity and specificity to antibody structure, and ultimately to disease pathogenesis, we have generated a panel of eight anti-DNA mAbs from an autoimmune MRL MpJ-lpr/lpr mouse and have assessed the binding properties of these antibodies. We find that none of our anti-DNA mAbs bind to RNA and only one low-affinity mAb cross-reacts with non-DNA antigens, albeit weakly. None of the mAbs in our panel bind double-stranded DNA exclusively. Antibodies that recognize single-stranded DNA can be categorized into two groups based on their affinity and apparent mode of binding. One group possesses relatively high affinity for oligo(dT) and may recognize single-stranded DNA ligands by accommodating thymine bases in hydrophobic pockets on the antigen binding site. The second group binds more weakly, apparently recognizes single-stranded DNA nonspecifically, and in some cases also binds double-stranded DNA. Although different mechanisms are used for binding single- and double-stranded ligands, the mode of DNA recognition appears conserved within groups of antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634294     DOI: 10.1021/bi9516788

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  The antigenic properties of bacterial DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Thermodynamic analysis of monoclonal antibody binding to duplex DNA.

Authors:  J Tanha; J S Lee
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

3.  Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.

Authors:  Sanjeev Kumar; Karen A Bunting; Jatinderpal Kalsi; John A Hinks; David S Latchman; Laurence H Pearl; David A Isenberg
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  The influence of DNA size on the binding of antibodies to DNA in the sera of normal human subjects and patients with systemic lupus erythematosus (SLE).

Authors:  D S Pisetsky; T C Gonzalez
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

5.  Lupus-specific antibodies reveal an altered pattern of somatic mutation.

Authors:  A J Manheimer-Lory; G Zandman-Goddard; A Davidson; C Aranow; B Diamond
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

6.  Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity.

Authors:  P C Swanson; R L Yung; N B Blatt; M A Eagan; J M Norris; B C Richardson; K J Johnson; G D Glick
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

7.  Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility.

Authors:  Neal B Blatt; Jeffrey J Bednarski; Roscoe E Warner; Francesco Leonetti; Kathryn M Johnson; Anthony Boitano; Raymond Yung; Bruce C Richardson; Kent J Johnson; Jonathan A Ellman; Anthony W Opipari; Gary D Glick
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

9.  A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus.

Authors:  Michelle F Cavallo; Anna M Kats; Ran Chen; James X Hartmann; Mirjana Pavlovic
Journal:  Autoimmune Dis       Date:  2012-12-05

10.  A role for complement in feedback enhancement of antibody responses by IgG3.

Authors:  Teresita Díaz de Ståhl; Jörgen Dahlstrom; Michael C Carroll; Birgitta Heyman
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.